Porr and Strabag, two construction companies, agreed to acquire Vamed, a provider of services for hospitals and other healthcare facilities, from Fresenius, a health care company, for €90m ($86m). “We have found a holistic and viable solution for the Vamed businesses, creating good prospects for the future. It is the best outcome for patients, for Vamed, and for Fresenius. With the exit from Vamed, our strategic portfolio restructuring has been completed as planned. Fresenius is already a simpler, stronger, and more innovative company due to the consistent implementation of #FutureFresenius. We now have even more opportunities to provide world-class therapies and improve people’s health,” Michael Sen, Fresenius CEO.